Welcome to our dedicated page for ALBANY INTERNATIONAL /DE/ SEC filings (Ticker: AIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ALBANY INTERNATIONAL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ALBANY INTERNATIONAL /DE/'s regulatory disclosures and financial reporting.
Albany International Corp. (AIN) has a large institutional holder reporting a sub‑5% position in its Class A common stock. American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research report beneficial ownership of 1,381,396 shares, or 4.8% of the class as of the event date.
They report sole voting power over 1,360,109 shares and sole dispositive power over 1,381,396 shares, with no shared voting or dispositive power. The securities are described as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Albany International.
Albany International Corp. reported that, during a meeting with a research analyst, it shared extra details about its ongoing exploration of strategic alternatives for its structures assembly business at the Amelia Earhart Drive Facility (AED Facility) in Salt Lake City, including a possible sale of all or part of that business. The company is selecting a financial advisor and building financial models for the AED Facility, which it may market as a whole, and it does not yet have an estimate of how long this work will take.
So far, interest has come from private equity investors, with more than ten inbound inquiries, rather than from strategic buyers. Management is also in ongoing discussions with a key customer about contract changes to offset cost increases. If a divestiture of the AED Facility is completed, the company expects the Adjusted EBITDA margin for its Albany Engineered Composites segment to be in the mid to high teens. This information was furnished under Regulation FD after an inadvertent selective disclosure and is framed as forward-looking and subject to uncertainty.
Albany International Corp. (AIN) reported that its President and CEO, who also serves as a director, bought additional shares of the company. On 11/17/2025, the executive purchased 2,300 shares of Class A common stock at a price of $42.0441 per share in an open-market transaction coded as a purchase. Following this transaction, the executive directly owned 19,895 shares of Class A common stock.
The report also lists several grants of restricted stock units under the Albany International Corp. 2023 Incentive Plan. These units each entitle the holder to receive one share of Class A common stock upon vesting, with various tranches scheduled to vest between March 1, 2024 and March 1, 2028.
Albany International Corp. reported a Q3 2025 net loss of $97.6 million on net revenues of $261.4 million. Operating loss was $116.5 million, driven by cumulative negative adjustments to long‑term contracts, including $147.3 million on CH‑53K programs that reduced profitability in Albany Engineered Composites (AEC). Earnings per share were −$3.37 (basic and diluted).
By segment, Q3 operating income was $43.1 million for Machine Clothing and an operating loss of $148.0 million for AEC. Year‑to‑date, net revenues were $861.6 million with a net loss of $71.2 million. Cash from operations for the first nine months was $78.8 million, while long‑term debt rose to $480.6 million under the $800 million revolver; the leverage ratio was 1.70x and the company remained in covenant compliance. The company repurchased $171.0 million of shares year‑to‑date, and Class A shares outstanding were 28.7 million as of October 15, 2025.
Albany International (AIN) reported Q3 2025 results highlighted by a one‑time aerospace charge and a strategic shift. Revenue was $261.4 million versus $298.4 million a year ago, reflecting a $46.0 million unfavorable CH‑53K impact. The company posted a GAAP net loss of $97.8 million (−$3.37 per diluted share), driven by a $147.3 million pre‑tax loss reserve and program adjustments on CH‑53K.
On an adjusted basis, net income was $20.6 million ($0.71 per diluted share) and adjusted EBITDA was $56.2 million, for an 18.3% margin. Machine Clothing revenue was $175.0 million with a 31.0% adjusted EBITDA margin; Engineered Composites revenue was $86.5 million, with CH‑53K effects masking LEAP program strength.
The company initiated a strategic review of its structures assembly business and reached a definitive agreement to conclude the Gulfstream contract, and withdrew full‑year guidance. Capital actions in the quarter included $50.5 million of share repurchases, $8.0 million in dividends, $18.3 million in capex, and $25.7 million of free cash flow. Cash was $108.3 million and total debt $480.6 million, for net debt of $372.3 million.
Albany International Corp. (AIN) reported that it will recognize an approximately $147 million loss reserve adjustment in the third quarter of 2025 related to performance on its CH-53K contract within the Engineered Composites (AEC) segment. The company also announced it will initiate a review of strategic alternatives for its structures assembly business.
The updates were disclosed alongside a press release furnished as Exhibit 99.1. These actions reflect contract performance impacts at AEC and a potential repositioning of the structures assembly business.
Albany International Corp. reporting person Willard C. Station, Executive Vice President and CFO, was granted a total of 38,488 Restricted Stock Units (RSUs) on 09/02/2025 under the 2023 Plan. The grant comprises 32,118 RSUs with staged vesting on 09/01/2026, 09/01/2027 and 09/01/2028 and 6,370 RSUs with staged vesting on 03/01/2026, 03/01/2027 and 03/01/2028. Each RSU converts to one share of Class A Common Stock at vesting and the reported price is $0 per unit.
Station Willard C, Executive Vice President and Chief Financial Officer, submitted an initial Section 16 Form 3 for Albany International Corp (AIN) reporting that no securities are beneficially owned. The filing indicates the reporting person serves as an officer and director and that the ownership position is nil, establishing the filer currently holds no direct or indirect equity stake in the company.
Christopher Eric Stone, an officer (President AEC) of Albany International Corp (AIN), received shares when Restricted Stock Units (RSUs) vested. On 08/12/2025, 6,905 RSUs granted under the 2023 Plan vested and were distributed as shares, and 1,975 shares were withheld to satisfy tax withholding at $62.80 per share, leaving 4,930 shares beneficially owned following the transaction. The filing also discloses unvested RSU awards: a tranche of RSUs with scheduled vesting in August 2026 and August 2027 from the August 12, 2024 grant, plus separate RSU grants vesting March 1 in 2025–2028 as detailed in the footnotes. The activity reflects routine compensation vesting and tax withholding.
American Century Investment Management, American Century Companies and Stowers Institute report beneficial ownership of 1,697,965 shares of Albany International Corp. Class A common stock, representing 5.6% of the class. The filing shows sole voting power over 1,524,650 shares and sole dispositive power over 1,697,965 shares as reported on this Schedule 13G.
The statement identifies ACIM as a wholly-owned subsidiary of ACC and notes ACIM is a registered investment adviser; ACC is controlled by Stowers Institute. The filing includes a certification that the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.